A new phenylpropanoid glucoside from Psorospermum tenuifolium Kotschy (Hypericaceae)
Town Planning Review · 01.03.2021 · 5 (1) · 31-36
DOI: 10.30495/tpr.2021.680493 ↗Kurz gefasst
Fachartikel in der Zeitschrift Town Planning Review, erschienen am 01.03.2021. Verfasst von Gervais Mouthé Happi und 6 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
A new phenylpropanoid glycoside named psorospermoside (1) possessing an allose unit was isolated from the Psorospermum tenuifolium Hook f. bark extract together with eleven known compounds. Their structures were elucidated using spectroscopic and spectrometric methods including 1D, 2D-NMR, and ESI-MS, as well as by comparison of their data with those reported in the literature. All the isolated compounds were assessed for their cytotoxicity effect on the human cervix carcinoma cell line KB3-1. Emodin (2) and its congener 2-geranylemodin (3) displayed significant cytotoxicity with IC50 values of 11.4 µM and 19.0µM, respectively. Furthermore, the chemotaxonomic significance of the isolated compounds was also discussed.
Schlagwörter
Zitieren
APA
Happi, G. M., Mbobda, A. S. W., Frese, M., Kouam, S. F., Tchouankeu, J. C., Lenta, B. N., & Sewald, N. (2021). A new phenylpropanoid glucoside from Psorospermum tenuifolium Kotschy (Hypericaceae). Town Planning Review, 5(1), 31-36. https://doi.org/10.30495/tpr.2021.680493
Vancouver
Happi GM, Mbobda ASW, Frese M, Kouam SF, Tchouankeu JC, Lenta BN, et al. A new phenylpropanoid glucoside from Psorospermum tenuifolium Kotschy (Hypericaceae). Town Planning Review. 2021;5(1):31-36. doi:10.30495/tpr.2021.680493
BibTeX
@article{Happi2021,
author = {Happi, Gervais Mouthé and Mbobda, Alexis Sylvain W. and Frese, Marcel and Kouam, Siméon F. and Tchouankeu, Jean Claude and Lenta, Bruno Ndjakou and Sewald, Norbert},
title = {A new phenylpropanoid glucoside from Psorospermum tenuifolium Kotschy (Hypericaceae)},
journal = {Town Planning Review},
year = {2021},
volume = {5},
number = {1},
pages = {31--36},
doi = {10.30495/tpr.2021.680493}
}
EUVIMED